| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 07/22/2004 | US20040142494 for specifically binding particulates such as cells, especially bacterial cells or hematopoietic cells and a means for detecting the particulates specifically bound to a platform |
| 07/22/2004 | US20040142475 Delivery systems for bioactive agents |
| 07/22/2004 | US20040142473 Means and methods for fibroblast-like or macrophage-like cell transduction |
| 07/22/2004 | US20040142465 Injectable hyaluronic acid derivative with pharmaceuticals/cells |
| 07/22/2004 | US20040142464 Transgenic human cells expressing superantigens/antiproliferative agents for use as gene therapeutic tools in cancer treatment ; tissue engineering |
| 07/22/2004 | US20040142453 Mycobacterial proteins, microorganisms producing them and their use for vaccines and for the detection of tuberculosis |
| 07/22/2004 | US20040142446 Methods and compositions for stabilizing microtubules and intermediate filaments in striated muscle cells |
| 07/22/2004 | US20040142445 Novel metalloprotease having aggrecanase activity |
| 07/22/2004 | US20040142431 Nucleotide sequences comprising restriction fragment length polymorphisms coding polypeptide with antiproliferative, antiviral and antiparasitic effects |
| 07/22/2004 | US20040142427 Nucleotide sequences coding lyase for use as tool in identifying treatments which prevent or inhibit tumor cell metastasis, inflammation and autoimmunity |
| 07/22/2004 | US20040142426 Novel proteins and methods for producing the proteins |
| 07/22/2004 | US20040142423 Novel polypeptides, DNAs encoding the same and use thereof |
| 07/22/2004 | US20040142421 Pacemake ion channel proteins and uses thereof |
| 07/22/2004 | US20040142420 Comprises nucleotide sequences coding cytokine for use as tool in identiying modulators for treatment of arthritis, inflammation and inflammatory bowel disease; gene therapy |
| 07/22/2004 | US20040142418 Novel neurotrophic factors |
| 07/22/2004 | US20040142417 Receptor proteins |
| 07/22/2004 | US20040142404 Designing cyclic peptide which modulates tyrosine kinase activity and can be used as potential treatment for asthma, eczema, food allergies, cancer, inflammatory bowel and autoimmune diseases; enzyme inhibitors |
| 07/22/2004 | US20040142395 Compositions and methods for identifying agents which modulate PTEN function and PI-3 kinase pathways |
| 07/22/2004 | US20040142393 Methods of use of compounds with preptin function |
| 07/22/2004 | US20040142390 Novel mammalian catecholamine receptor genes and uses |
| 07/22/2004 | US20040142388 Method for detecting chronic dementia diseases, and corresponding VGF peptides and detection reagents |
| 07/22/2004 | US20040142385 Cell wall mannoproteins and active epitopes from candida albicans and antibodies recognizing them |
| 07/22/2004 | US20040142374 PAAD domain-containing polypeptides, encoding nucleic acids, and methods of use |
| 07/22/2004 | US20040142372 Comprises nucleotide sequences coding cytokine binding protein for use in identifying modulators for treatment of cell proliferative and inflammatory disorders |
| 07/22/2004 | US20040142368 Method of identifying therapeutic agents |
| 07/22/2004 | US20040142363 N-acetylglycosaminyl transferase genes |
| 07/22/2004 | US20040142361 Compositions and methods for the therapy and diagnosis of breast cancer |
| 07/22/2004 | US20040142357 Novel telomerase inhibitors and uses therefor |
| 07/22/2004 | US20040142354 used to diagnose and/or treat a wide variety of liver and other disorders (cancer) and tracing hepatocyte lineage; genetic engineering |
| 07/22/2004 | US20040142352 Isolated human Ras-like proteins, nucleic acid molecules encoding these human Ras-like proteins, and uses thereof |
| 07/22/2004 | US20040142348 solid phase synthesis; for diagnosis/treatment/prophyaxis; animal models; genetic engineering |
| 07/22/2004 | US20040142346 Antisense oligonucleotide modulation of tumor necrosis factor-alpha (TNF-alpha) expression |
| 07/22/2004 | US20040142333 for diagnostics, biosensors, bioreactors, drug screening and therapy; genetic engineering |
| 07/22/2004 | US20040142317 Use of amino acid transporter atbo,+ as a delivery system for drugs and prodrugs |
| 07/22/2004 | US20040142050 Use of Bowman Birk Inhibitor for the treatment of multiple sclerosis and other autoimmune diseases |
| 07/22/2004 | US20040142048 e.g., blue fruit extracts with epigallocatechin gallate, epicatechin, epicatechin gallate, or epigallocatechin; treating primary and metastatic cancers |
| 07/22/2004 | US20040142047 Korean acanthopanax senticosus extract, protein extract, crude protein-polysaccharide which were extracted from korean acanthopanax senticosus, and immunoregulating compositions comprising the same and use thereof |
| 07/22/2004 | US20040142037 Lactoferrin compositions and methods of wound treatment |
| 07/22/2004 | US20040142014 Method and apparatus for reducing tissue damage after ischemic injury |
| 07/22/2004 | US20040142005 treating a cardiovascular disease, especially preventing restenosis in a blood vessel which may occur following a cardiovascular procedure, |
| 07/22/2004 | US20040142002 Recombinant poxvirus |
| 07/22/2004 | US20040142001 contains Radix, Cortex, Medulla, Rhizoma, Caulis, Herba, Semen, Rhizoma, Olibanum, Fructus, Myrrha, Gypsum, Folium, Herba, Polyporus, Stigma, Phaseolus and other natural components; preferably further comprises Ganoderma Lucidum. |
| 07/22/2004 | US20040141997 Methods for treating or preventing infections from coagulase-negative staphylococci |
| 07/22/2004 | US20040141996 deglycosylated HIV proteins comprise at least one epitope region which does not elicit an immune response in man when encountered by infection or environmental exposure but does elicit an immune response in a non-human species. |
| 07/22/2004 | US20040141994 Herpes simplex virus recombinase comprising an alkaline nuclease and a single stranded DNA binding polypeptide; has polynucleotide strand exchange activity; cloning kit |
| 07/22/2004 | US20040141993 FAFSD target peptide or an anlogue covalently linked to a helper T cell epitope; reducing adherence to the urinary tract mucosa by type 1 fimbriated uropathogenic enterobacteriae to prevent urinary tract infection |
| 07/22/2004 | US20040141992 derived from the same antigen as the substance eliciting the allergic reaction; contains an epitope different from that evoking the allergic reaction, yet does not elicit the allergic reaction |
| 07/22/2004 | US20040141991 novel prostatic acid phosphatase and corresponding coding region derived from mouse; immunizing a subject with a xenogeneic polypeptide antigen, either alone, as part of a viral antigen construct, or as part of a pulsed dendritic cell preparation. |
| 07/22/2004 | US20040141989 polypeptides comprising segments of prostate gland proteins and to DNA codes for such polypeptides used in vaccines for prophylaxis of tumors |
| 07/22/2004 | US20040141982 Use of genetically engineered antibodies to treat multiple myeloma |
| 07/22/2004 | US20040141981 administering biological conjugates comprising chlorotoxin sensitive cytoplasmic proteins, used for the screening and prophylaxis of cancer |
| 07/22/2004 | US20040141978 Angiogenesis related molecules |
| 07/22/2004 | US20040141976 compositions and methods to suppress the activation and/or proliferation of mesenchymally derived cells, as well as cells with abnormal growth characteristics; inhibit or eliminate fibrosis |
| 07/22/2004 | US20040141975 Nucleic acid and corresponding protein entitled 98P4B6 useful in treatment and detection of cancer |
| 07/22/2004 | US20040141973 IPG antagonists for the treatment of conditions involving mast cells, basophils and eosinophils |
| 07/22/2004 | US20040141972 Compounds, compositions and methods for the treatment of diseases characterized by A-33 related antigens |
| 07/22/2004 | US20040141971 Compounds, compositions and methods for the treatment of diseases characterized by A-33 related antigens |
| 07/22/2004 | US20040141970 recombinant production of novel DNA and novel polypeptides the presence of which is associated with inflammatory diseases (inflammation associated antigens) and/or cancer; diagnosis and treatment of conditions characterized by such antigens |
| 07/22/2004 | US20040141967 Methods and compositions for treating macrophage-mediated diseases |
| 07/22/2004 | US20040141966 Inhibition of leukocyte adhesion |
| 07/22/2004 | US20040141962 Regulation of human prostasin-lik serine protease |
| 07/22/2004 | US20040141961 Dnase inhibitors; administering actin; cystic fibrosis, autoimmune diseases |
| 07/22/2004 | US20040141959 Somatic cells with ablated PrP gene and methods of use |
| 07/22/2004 | US20040141953 delivery of a neurotrophin to targeted defective, diseased or damaged cholinergic neurons |
| 07/22/2004 | US20040141952 Death domain containing receptor 5 |
| 07/22/2004 | US20040141951 administering monokine induced by interferon gamma and an IFN-gamma inducible protein to inhibit receptor expression, receptor internalization, signal transduction, transmigration, desensitization, degranulation, mediator release, oxidase activity |
| 07/22/2004 | US20040141950 Immunostimulatory combinations |
| 07/22/2004 | US20040141949 Treatment of mucositis |
| 07/22/2004 | US20040141947 Method for treatment of demyelinating central nervous system disease |
| 07/22/2004 | US20040141946 Methods of treating neurological conditions with hematopoietic growth factors |
| 07/22/2004 | US20040141945 novel material which combines cell-adhesive proteins such as collagen with GAG polymers to construct an environment similar to an extracellular matrix, capable of controlling differentiation and proliferation of cells |
| 07/22/2004 | US20040141939 Cosmetic or dermatological use of peptides for promoting adhesion between skin cells |
| 07/22/2004 | US20040141918 Nucleotide and deduced amino acid sequences of tumor gene Int6 |
| 07/22/2004 | DE10162867A1 New fusion protein and its complexes with nucleic acid, useful for treating solid tumors, comprises membrane-penetration and cell-damaging domains |
| 07/22/2004 | CA2764405A1 Pharmaceutical preparations for treatments of diseases and disorders of the breast |
| 07/22/2004 | CA2551760A1 Antimicrobial composition for local use on mucosal membranes and skin |
| 07/22/2004 | CA2512735A1 Eye-drop vaccine containing copolymer 1 for therapeutic immunization |
| 07/22/2004 | CA2512629A1 Secreted polypeptide species (fragments from chitotriosidase) reduced in cardiovascular disorders |
| 07/22/2004 | CA2512553A1 Metastin derivatives and their use |
| 07/22/2004 | CA2512512A1 Uses of hmgb, hmgn, hmga proteins |
| 07/22/2004 | CA2512365A1 Rhesus her2/neu, nucleotides encoding same, and uses thereof |
| 07/22/2004 | CA2512138A1 Kim-1 antagonists and use to modulate immune system |
| 07/22/2004 | CA2512052A1 Human growth hormone crystals and methods for preparing them |
| 07/22/2004 | CA2511966A1 Modulators of receptors for parathyroid hormone and parathyroid hormone-related protein |
| 07/22/2004 | CA2511907A1 Compositions and methods for diagnosing and treating colon cancers |
| 07/22/2004 | CA2511879A1 Methods of treating and/or preventing autoimmune diseases |
| 07/22/2004 | CA2511838A1 Uses of mammalian cytokine; related reagents |
| 07/22/2004 | CA2511823A1 Combination therapy with co-stimulatory factors |
| 07/22/2004 | CA2511815A1 Polymer conjugates of cytokines, chemokines, growth factors, polypeptide hormones and antagonists thereof with preserved receptor-binding activity |
| 07/22/2004 | CA2511814A1 Polymer conjugates of interferon-beta with enhanced biological potency |
| 07/22/2004 | CA2511648A1 Topical composition and methods for treatment of aged or environmentally damaged skin |
| 07/22/2004 | CA2511557A1 Method to increase fibronectin |
| 07/22/2004 | CA2511538A1 Immunostimulatory combinations |
| 07/22/2004 | CA2511535A1 P53 treatment of papillomavirus and carcinogen-transformed cells in hyperplastic lesions |
| 07/22/2004 | CA2510572A1 Delivery of peroxide-generating enzymes to the vaginal tract |
| 07/22/2004 | CA2509755A1 Compositions and methods for the prevention and control of insulin-induced hypoglycemia |
| 07/22/2004 | CA2509060A1 Compositions and methods of using collagen and mmpi |
| 07/22/2004 | CA2508127A1 Compounds that bind p2y2 or p2y1 receptors |
| 07/22/2004 | CA2507956A1 Wound care compositions |
| 07/22/2004 | CA2503043A1 Compositions and methods for the diagnosis and treatment of tumor |